NCT06562673 2025-12-29
IACE-OS
Shanghai 6th People's Hospital
Phase 1/2 Completed
Clinical Trials
54 trialsNCT03086681 2025-07-29
ECWHCCFLACC
First Affiliated Hospital of Guangxi Medical University
Phase 2 Completed
NCT03797625 2025-07-23
Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
Fudan University
Phase 2 Completed
NCT06965231 2025-05-11
FUMS-EDJS2024
Fudan University
Phase 2 Recruiting
NCT06301828 2024-03-08
Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors
Nanjing First Hospital, Nanjing Medical University
Phase 2 Unknown
NCT05203276 2023-06-22
Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC
The First People's Hospital of Lianyungang
Phase 2 Unknown
NCT05907512 2023-06-22
Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma
Fudan University
Phase 2 Unknown
NCT02350517 2023-02-16
Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer
Sun Yat-sen University
Phase 2 Completed
NCT05574998 2022-10-12
FTANLCNDG
Qianfoshan Hospital
Phase 2 Unknown
NCT05529355 2022-09-07
Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer
Anhui Chest Hospital
Phase 2 Unknown
NCT02749526 2022-07-29
Endostar Combined With MPFC Adjuvant Treatment of Esophageal Cancer Clinical Trial
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Terminated
NCT05298020 2022-03-28
Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer
The Affiliated Hospital of Xuzhou Medical University
Phase 2 Unknown
NCT02237924 2022-02-14
Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University
Phase 2 Completed
NCT05177237 2022-01-04
Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma
Jiangxi Provincial Cancer Hospital
Phase 2 Unknown
NCT02636231 2021-02-03
Endostar for Locally Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Unknown
NCT04613284 2020-11-03
RELIEF
Shanghai Chest Hospital
Phase 4 Unknown
NCT03989830 2020-10-23
SLICER
Peking University
Phase 2 Unknown
NCT02444949 2020-06-24
A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma
China Three Gorges University, Yichang, China
Phase 2 Completed
NCT04274270 2020-03-19
SBRTLCES
Peking University Third Hospital
Phase NA Unknown
NCT04303130 2020-03-10
Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT03121833 2019-12-26
Endostar Combined With Chemotherapy for Stage Ⅳ Soft Tissue Sarcoma
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Completed
NCT04121975 2019-10-10
CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT01907529 2019-08-09
TENDENCY
Hebei Medical University Fourth Hospital
Phase 2/3 Unknown
NCT03932266 2019-04-30
Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
NCT03907098 2019-04-08
Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT02902432 2019-01-31
A Trial of Endostar in Patients With Carcinoma of the Head and Neck
China International Medical Foundation
Phase 2 Unknown
NCT03706703 2018-10-17
Rh-Endostatin (Endostar®) Continuous Intravenous Infusion
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 2 Unknown
NCT03649945 2018-08-28
Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer
First Affiliated Hospital of Guangxi Medical University
Phase 2 Unknown
NCT03614065 2018-08-03
Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT03588494 2018-07-17
Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer
Affiliated Hospital of North Sichuan Medical College
Phase 2/3 Unknown
NCT02590133 2017-12-22
A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC
Sun Yat-sen University
Phase 2 Unknown
NCT03123445 2017-04-21
Endostar First-line Treatment of Advanced NSCLC
China Medical University, China
Phase 2 Unknown
NCT02579564 2016-10-21
Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients
Xinqiao Hospital of Chongqing
Phase 3 Unknown
NCT02907710 2016-09-20
Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University
Phase 3 Unknown
NCT02615106 2016-06-14
Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown
NCT02665702 2016-01-28
Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
Fudan University
Phase 2 Unknown
NCT01430013 2015-11-04
Trial of Endostar Combined With CHOPT for T Cell Lymphoma
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT02497118 2015-07-14
Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC
Tianjin Medical University Cancer Institute and Hospital
Phase 4 Completed
NCT00842491 2015-05-19
Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer
Peking University
Phase 2 Completed
NCT02375022 2015-03-24
Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations
Zhejiang University
Phase 2 Unknown
NCT02350361 2015-01-29
Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.
Peking University Third Hospital
Phase 2/3 Unknown
NCT01612286 2014-02-19
Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT02005120 2013-12-20
Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC
Zhejiang University
Phase 2 Unknown
NCT02008422 2013-12-11
Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer
Xinjiang Medical University
Phase 3 Unknown
NCT02001168 2013-12-04
Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB
Xinjiang Medical University
Phase 3 Unknown
NCT01218594 2012-10-17
DP-EN-RT
Sun Yat-sen University
Phase 2 Unknown
NCT01687439 2012-09-19
Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC)
Fudan University
Phase 2 Completed
NCT01310478 2011-03-08
Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer
Fudan University
Phase 1 Unknown
NCT00657423 2010-09-17
Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)
Xijing Hospital
Phase 3 Unknown
NCT00974324 2010-09-15
PTCL
Fudan University
Phase 2 Unknown